Skip to main content
Clinical Trials/ACTRN12607000130460
ACTRN12607000130460
Completed
Phase 2

A pilot study to investigate the efficacy and tolerability of a combination of fenugreek/phaseolamin as a potential weight loss agent when given as part of a muesli bar in moderately obese patients

Southern European Health Marketing Ltd0 sites39 target enrollmentFebruary 15, 2007

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Obesity
Sponsor
Southern European Health Marketing Ltd
Enrollment
39
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 15, 2007
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Southern European Health Marketing Ltd

Eligibility Criteria

Inclusion Criteria

  • Overweight as defined by body mass index 30\-40kg/m2Generally healthyWeight stable over previous 3 monthsWilling and able to give written informed consent.

Exclusion Criteria

  • Diabetic (receiving pharmacological treatments for diabetes)Pregnant, breastfeeding, or intending to become pregnant during the studyAny medications, or medical conditions that might, in the opinion of the Principal Investigator, affect participant safety or outcomeCurrently on an alternative weight loss programme or planning to start a programme during the study durationHas a pace\-makerPlanning international travel during the study.

Outcomes

Primary Outcomes

Not specified

Similar Trials